Tag: Heart / Stroke-Related: High Cholesterol
Levels of Total, LDL Cholesterol Continue to Fall in the U.S.
Eliminating trans fats from the U.S. diet may be one factor in this healthy trend
AHA: Inclisiran Twice Yearly May Effectively Control Cholesterol
Injectable medication is a next-level PCSK9 inhibitor
AHA: Evolocumab Can Help Substantially Reduce LDL
Patients taking evolocumab and statins showed a reduction in arterial plaque volume
PCSK9, LDL-C Link Only Seen for Patients With Highest HbA1c
In patients with type 1 diabetes, correlation only seen for those in the highest tertile of HbA1c
Low and High HDL Tied to Increased Risk of Mortality
Study casts doubt on HDL as an independent cardiovascular disease risk factor
Child-Parent Screening for Hypercholesterolemia Feasible
Screening feasible in primary care at routine child immunization visits for children aged 1 to 2 years
Both Statin, Non-Statin Therapies Effective for Lowering LDL
Dietary changes, other meds, and even surgery can lower cardiovascular risk similarly to statins
Evolocumab Safe, Effective for Those With Dysglycemia, MetS
Reduction in LDL-C in all subgroups, including those with, without dysglycemia and metabolic syndrome
Ezetimibe Plus Rosuvastatin Bests Rosuvastatin Alone
Combo tx linked to significant reductions in LDL, total cholesterol, triglycerides versus rosuvastatin
PCSK9 Inhibitor Use Not Found to Be Cost-Effective
In patients with familial hypercholesterolemia, atherosclerotic cardiovascular disease
